Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2013. The document serves as a notification of a transaction involving a Person Discharging Managerial Responsibility (PDMR) in the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain financial performance data.
Material Changes
The only material change disclosed is the purchase of 499 Ordinary Shares by Mr. S M Bicknell, a Person Discharging Managerial Responsibility, on March 25, 2013. The transaction price was 1523.45 pence per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory disclosure of a director's share purchase in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investors to Verify
- Mr. S M Bicknell purchased 499 Ordinary Shares of GlaxoSmithKline plc.
- The purchase price was 1523.45 pence per share.
- The transaction date and notification date were both March 25, 2013.
- The filing contains no financial performance metrics or strategic outlook.